NEW YORK (360Dx) – Bio-Techne this week reported total revenues for its fiscal third quarter of $164 million, up 14 percent year over year from $144.0 million, and matching Wall Street analysts' average estimate for the quarter.  

For the three months ended March 31, the company said that its diagnostics revenues grew 10 percent year over year to $28.5 million from $26.0 million in Q3 2017. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.